JT
RYTM icon

Jupiter Topco’s Rhythm Pharmaceuticals RYTM Stock Holding History

Jupiter Topco’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
+925,490
New +$83.7M 0.04% 302

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco's RYTM Position: Q2 2026 in Review

Jupiter Topco opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 925,490 shares worth $103M. The stake represents 0.04% of the portfolio and ranks #302 among its holdings.

280 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Jupiter Topco held 925,490 shares of Rhythm Pharmaceuticals worth $103M as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.04% of Jupiter Topco's portfolio in Q2 2026, its #302 holding.
  • 280 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.